Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Xencor (XNCR)

Xencor Q2 revenue rises to $43.6 million; net loss narrows to $30.8 million

Positive Impact 3 of 5 earnings Written later

Xencor reported second-quarter 2025 results, with revenue of $43.6 million, up from $23.9 million a year earlier, driven mainly by milestone revenue from Incyte. The net loss attributable to Xencor narrowed to $30.8 million, or $(0.41) per share, from $67.3 million, or $(1.09) per share, a year earlier, and the company expects to end 2025 with between $555 million and $585 million in cash and marketable debt securities.

Key points

  • Q2 2025 revenue was $43.6 million versus $23.9 million in Q2 2024, mainly milestone revenue from Incyte.
  • Q2 2025 net loss attributable to Xencor was $30.8 million, or $(0.41) per share, versus $67.3 million, or $(1.09) per share, in Q2 2024.
  • Cash, cash equivalents and marketable debt securities totaled $663.8 million as of June 30, 2025.
  • Xencor expects year-end 2025 cash of $555 million to $585 million and funding into 2028.

The filing

CompanyXencor (XNCR)
Form8-K, current report
Filed with the SECAug 6, 2025, 4:01 PM ET
Accession number0001326732-25-000074

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.